WHO calls halt to solidarity trial of HCQ

The World Health Organization said it has halted studies of
hydroxychloroquine in its Solidarity Trial after The Lancet published
a piece that said a higher mortality rate was estimated for critically
ill patients who received the drug, when used alone or with a
macrolide.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/who-calls-halt-to-solidarity-trial-of-hcq/articleshow/75990966.cms

Comments

Popular posts from this blog

Clinical Database Management Professional Vacancy @ Teva

Pharma Production Executive Post Vacancy @ Intas

Biotecnika Times – Newsletter 28.02.2020 – DST Women Scientist WOS B, DBT-IOC Recruitment